ARMP
AMEX · Biotechnology
Armata Pharmaceuticals Inc
$8.37
-0.98 (-10.48%)
Open$9.09
Previous Close$9.35
Day High$9.09
Day Low$8.25
52W High$16.34
52W Low$0.90
Volume—
Avg Volume30.6K
Market Cap340.40M
P/E Ratio—
EPS$-1.30
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+108.5% upside
Current
$8.37
$8.37
Target
$17.45
$17.45
$10.78
$17.45 avg
$19.60
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.93M | 5.65M | 51.72M |
| Net Income | -21,688,870 | -18,590,460 | -16,237,176 |
| Profit Margin | -365.6% | -347.3% | -31.4% |
| EBITDA | -44,654,777 | -40,401,941 | -19,844,642 |
| Free Cash Flow | — | — | -12,228,215 |
| Rev Growth | +5.0% | +5.0% | -2.8% |
| Debt/Equity | — | — | 1.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |